NDC 61703-303 – Cytarabine
Cytarabine 20 mg/mL · Injection, Solution · Intravenous
Product NDC61703-303
Product details
- Brand name
- Cytarabine
- Generic name
- Cytarabine
- Labeler
- Hospira, Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA072168
- Marketed since
- August 31, 1990
- Listing expires
- December 31, 2027
- Pharmacologic class
- Nucleoside Metabolic Inhibitor
Active ingredients
- Cytarabine 20 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 61703-303-46 | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (61703-303-46) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE | Aug 31, 1990 |
Recalls mentioning this NDC
- D-1680-2012 Sep 26, 2012 · Class II
The affected lots of Carboplatin Injection, Cytarabine Injection, Methotrexate Injection, USP, and Paclitaxel Injection are being recalled due to visible particles embedded in the glass located at…
Other cytarabine products
- 63323-120 Cytarabine 100 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 68083-337 Cytarabine 100 mg/mL · Injection, Solution · Gland Pharma Limited
- 68083-343 Cytarabine 20 mg/mL · Injection, Solution · Gland Pharma Limited
- 61703-155 Cytarabine 100 mg/mL · Injection, Solution · Hospira, Inc.
- 61703-304 Cytarabine 20 mg/mL · Injection, Solution · Hospira, Inc.
- 61703-305 Cytarabine 20 mg/mL · Injection, Solution · Hospira, Inc.
- 61703-319 Cytarabine 100 mg/mL · Injection, Solution · Hospira, Inc.
- 71288-108 Cytarabine 20 mg/mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 71288-109 Cytarabine 2 g/20mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 71288-168 Cytarabine 20 mg/mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 71288-169 Cytarabine 20 mg/mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 25021-223 Cytarabine 100 mg/mL · Injection, Solution · Sagent Pharmaceuticals